财经
财经
首页DTXMF • OTCMKTS
Deltex Medical Group Ord Shs
$0.095
8月8日, GMT-4 00:18:48 · USD · OTCMKTS · 免责声明
股票在美国上市的证券
昨日收盘价
$0.095
年度波幅
$0.10 - $0.10
市值
75.84万 GBP
市盈率
-
股息率
-
市场资讯
财务信息
损益表
收入
净收入
(GBP)2024年12月年同比变化
收入
49.60万38.35%
经营支出
53.75万61.41%
净收入
-62.55万-67.92%
净利润率
-126.11-21.36%
每股收益
息税折旧摊销前利润
-18.82万-53.05%
有效税率
总资产
负债总额
(GBP)2024年12月年同比变化
现金及短期投资
24.20万-65.67%
总资产
438.60万-26.06%
负债总额
293.30万5.16%
权益总额
145.30万
发行在外的股份
18.96亿
市净率
资产回报率
-11.06%
资本回报率
-14.00%
现金净变动
(GBP)2024年12月年同比变化
净收入
-62.55万-67.92%
来自运营的现金
-2.30万94.83%
投资现金
-1.10万82.81%
融资现金
4000.00-99.50%
现金净变动
-4.20万-114.05%
自由现金流
-9.42万41.59%
简介
Deltex Medical Group is a medical technology company based in Chichester that produces blood monitoring and fluid management equipment for use in surgical operations. It has sold 3000 of its main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay. According to the National Institute for Health and Care Excellence it could save £1000 per operation and could be used on more than 800,000 patients a year. As it is inserted into the gullet, it reduces the risk of infection that comes with monitoring using a tube inserted through a vein into the heart. Each probe costs about £100. It secured approval from the NHS Supply Chain in 2012 after a tender process, to sell cardiac output monitoring equipment to the NHS in England, meaning that individual NHS trusts did not have to go through a tender process. In November 2016 an NHS hospital bought six, the largest order since 2014. The cash crisis affecting the NHS has meant that few machines have been bought. Wikipedia
成立时间
2000
员工数量
24
一探究竟
您可能感兴趣的股票
此列表是根据近期的搜索内容、关注的证券以及其他活动生成的。了解详情

所有数据和信息均按“原样”提供,仅供个人参考,并非金融建议,不可用于交易目的,亦不可用于提供投资、税务、法律、会计或其他方面的建议。Google 并非投资顾问,也不是金融顾问,并且对此列表中的任何一家公司或该等公司发行的所有证券不发表任何看法、建议或观点。在进行任何交易之前,请先咨询您的经纪人或金融代表,以便核实价格。了解详情
搜索
清除搜索内容
关闭搜索框
Google 应用
主菜单